Literature DB >> 11461083

Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients.

P Keohavong1, H H Mady, W M Gao, J M Siegfried, J D Luketich, M F Melhem.   

Abstract

Mutations in the K- ras gene are very common in lung tumours and are implicated in the development of lung cancer, but the timing of their occurrence remains poorly understood. We investigated K- ras mutations in cell samples microdissected by laser capture microscopy at multiple sites from lung tissue sections representing tumour tissue and matched histologically normal tissue obtained from 48 lung cancer patients. K- ras mutations were detected in cell samples from 10 of 38 (26.3%) lung adenocarcinomas and in none of the histologically normal or tumour cell samples taken from 10 lung squamous cell carcinomas. Of the K- ras mutation-positive adenocarcinomas, in 4 cases a mutation was found in only the tumour tissue, in 1 case a mutation was found only in the histologically normal tissue, and in 5 cases mutations were found in both the tumour tissue and histologically normal tissue. Among these 5 cases, 2 had identical mutations in both the tumour tissue and histologically normal tissue, 2 had 1 mutation in the tumour tissue and 2 mutations in the histologically normal tissue, 1 of which was identical to the mutation found in the tumour, and 1 case had 2 codon 12 mutations in tumour tissue and 2 mutations, in codons 9 and 11, in histologically normal tissue. These results showed that K- ras mutations are frequent in histologically normal cells taken from outside lung adenocarcinomas and suggest that some of these mutations may represent early events which could pave the way of lung carcinogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11461083      PMCID: PMC2364035          DOI: 10.1054/bjoc.2001.1913

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive method.

Authors:  P Keohavong; D Zhu; A C Melacrinos; M A DeMichele; R J Weyant; J D Luketich; J R Testa; M Fedder; J M Siegfried
Journal:  Int J Cancer       Date:  1997-04-22       Impact factor: 7.396

2.  Laser capture microdissection.

Authors:  M R Emmert-Buck; R F Bonner; P D Smith; R F Chuaqui; Z Zhuang; S R Goldstein; R A Weiss; L A Liotta
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.

Authors:  P Keohavong; D Zhu; T L Whiteside; P Swalsky; A Bakker; E M Elder; J M Siegfried; S Srivastava; S D Finkelstein
Journal:  Anal Biochem       Date:  1997-05-01       Impact factor: 3.365

4.  K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.

Authors:  D Zhu; P Keohavong; S D Finkelstein; P Swalsky; A Bakker; J Weissfeld; S Srivastava; T L Whiteside
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

5.  K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.

Authors:  R E Wilentz; C H Chung; P D Sturm; A Musler; T A Sohn; G J Offerhaus; C J Yeo; R H Hruban; R J Slebos
Journal:  Cancer       Date:  1998-01-01       Impact factor: 6.860

6.  Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions.

Authors:  G Sozzi; M Miozzo; U Pastorino; S Pilotti; R Donghi; M Giarola; L De Gregorio; G Manenti; P Radice; F Minoletti
Journal:  Cancer Res       Date:  1995-01-01       Impact factor: 12.701

7.  High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer.

Authors:  M S Yakubovskaya; V Spiegelman; F C Luo; S Malaev; A Salnev; I Zborovskaya; A Gasparyan; B Polotsky; Z Machaladze; A C Trachtenberg
Journal:  Int J Cancer       Date:  1995-12-11       Impact factor: 7.396

8.  Detection of K-ras mutations in lung carcinomas: relationship to prognosis.

Authors:  P Keohavong; M A DeMichele; A C Melacrinos; R J Landreneau; R J Weyant; J M Siegfried
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

9.  K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.

Authors:  W H Westra; I O Baas; R H Hruban; F B Askin; K Wilson; G J Offerhaus; R J Slebos
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

10.  Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung.

Authors:  T Urban; S Ricci; R Lacave; M Antoine; M Kambouchner; F Capron; J F Bernaudin
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

View more
  4 in total

1.  Low-frequency KRAS mutations are prevalent in lung adenocarcinomas.

Authors:  Meagan B Myers; Karen L McKim; Fanxue Meng; Barbara L Parsons
Journal:  Per Med       Date:  2015-03       Impact factor: 2.512

Review 2.  Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Authors:  Brielle A Parris; Hannah E O'Farrell; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

3.  Biochip-based detection of KRAS mutation in non-small cell lung cancer.

Authors:  Gernot Kriegshäuser; Gerhild Fabjani; Barbara Ziegler; Sabine Zöchbauer-Müller; Adelheid End; Robert Zeillinger
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

4.  Restoration of miRNA-143 Expression Inhibits Growth and Migration of MKN-45 Gastric Cancer Cell Line.

Authors:  Nayer Hosseinahli; Tahereh Zeinali; Nasrin Hosseinahli; Leila Karimi; Dariush Shanehbandi; Behzad Mansoori; Ali Mohammadi; Tohid Kazemi; Khalil Hajiasgharzadeh; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2020-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.